PL1697326T3 - Krystaliczna postać chinoliny i sposób jej wytwarzania - Google Patents

Krystaliczna postać chinoliny i sposób jej wytwarzania

Info

Publication number: PL1697326T3
Authority: PL; Poland
Prior art keywords: crystal form; production; quinoline compound; stability; drug substance
Prior art date: 2003-12-26

Application number

PL04807807T

Other languages

English (en)

Inventor

Yoshio Ohara

Yasutaka Takada

Hiroo Matsumoto

Akihiro Yoshida

Original Assignee

Nissan Chemical Ind Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2003-12-26

Filing date

2004-12-17

Publication date

2011-12-30

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34736450&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1697326(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2004-12-17 Application filed by Nissan Chemical Ind Ltd filed Critical Nissan Chemical Ind Ltd

2011-12-30 Publication of PL1697326T3 publication Critical patent/PL1697326T3/pl

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/12—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D215/14—Radicals substituted by oxygen atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Epidemiology (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Quinoline Compounds (AREA)
Plural Heterocyclic Compounds (AREA)

PL04807807T 2003-12-26 2004-12-17 Krystaliczna postać chinoliny i sposób jej wytwarzania PL1697326T3 (pl)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
JP2003431788		2003-12-26
PCT/JP2004/019451 WO2005063711A1 (en)	2003-12-26	2004-12-17	Crystal form of quinoline compound and process for its production
EP04807807A EP1697326B1 (en)	2003-12-26	2004-12-17	Crystal form of quinoline compound and process for its production

Publications (1)

Publication Number	Publication Date
PL1697326T3 true PL1697326T3 (pl)	2011-12-30

Family

ID=34736450

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL04807807T PL1697326T3 (pl)	2003-12-26	2004-12-17	Krystaliczna postać chinoliny i sposób jej wytwarzania

Country Status (21)

Country	Link
US (19)	US20070112024A1 (pl)
EP (1)	EP1697326B1 (pl)
JP (7)	JP5186108B2 (pl)
KR (11)	KR20070001910A (pl)
CN (2)	CN102321019B (pl)
AT (1)	ATE518835T1 (pl)
AU (2)	AU2004309241A1 (pl)
CA (1)	CA2551050C (pl)
CY (1)	CY1112464T1 (pl)
DK (1)	DK1697326T3 (pl)
ES (1)	ES2367172T3 (pl)
IL (1)	IL176470A (pl)
MX (1)	MX338019B (pl)
NZ (1)	NZ548041A (pl)
PL (1)	PL1697326T3 (pl)
PT (1)	PT1697326E (pl)
RU (1)	RU2370489C2 (pl)
SI (1)	SI1697326T1 (pl)
TW (1)	TWI328006B (pl)
WO (1)	WO2005063711A1 (pl)
ZA (1)	ZA200605658B (pl)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2513837A1 (en)	2003-02-12	2004-08-26	Paul Adriaan Van Der Schaaf	Crystalline forms of pitavastatin calcium
TWI328006B (en)	2003-12-26	2010-08-01	Nissan Chemical Ind Ltd	Crystal form of quinoline compound and process for its production
US7801272B2 (en) *	2007-09-28	2010-09-21	Rigaku Corporation	X-ray diffraction apparatus and X-ray diffraction method
WO2011089623A2 (en) *	2010-01-20	2011-07-28	Cadila Healthcare Limited	Process for preparing pitavastatin and pharmaceutically acceptable salts thereof
KR101158517B1 (ko)	2010-04-29	2012-06-21	동방에프티엘(주)	고 순도 피타바스타틴 칼슘염 결정형 ａ의 제조방법
WO2012025939A1 (en)	2010-08-25	2012-03-01	Cadila Healthcare Limited	Pitavastatin calcium and process for its preparation
EP3178812A1 (en)	2010-11-12	2017-06-14	Hetero Research Foundation	Novel polymorphs of pitavastatin calcium
RU2452939C1 (ru) *	2011-01-18	2012-06-10	Закрытое акционерное общество "Научные приборы"	Рентгенодифракционный способ идентификации партий фармацевтической продукции
ITMI20111475A1 (it) *	2011-08-02	2013-02-03	Dipharma Francis Srl	Forme cristalline di pitavastatina sale di calcio
PT2751081T (pt) *	2011-09-12	2017-04-04	D O O Farma Grs	Forma polimórfica de pitavastatina cálcica
WO2013098773A1 (en) *	2011-12-28	2013-07-04	Dr. Reddy's Laboratories Limited	Crystalline forms of pitavastatin calcium
US20150164809A1 (en) *	2012-08-08	2015-06-18	Kowa Company, Ltd.	Medicine
IN2015DN03012A (pl) *	2012-09-27	2015-10-02	Nissan Chemical Ind Ltd
JP2014034574A (ja) *	2013-01-25	2014-02-24	Kowa Company Ltd	医薬
BR112015022849B1 (pt)	2013-03-15	2020-02-18	Asieris Pharmaceutical Technologies Co., Ltd.	Sais de adição de base de nitroxolina, usos e processo para preparação dos mesmos, bem como seu cristal, composição farmacêutica e processo para preparação da mesma
CN105213319A (zh) *	2015-09-17	2016-01-06	青岛华之草医药科技有限公司	一种降血脂药物匹伐他汀钙组合物干混悬剂
JP2016222714A (ja) *	2016-09-20	2016-12-28	興和株式会社	医薬
WO2021181360A1 (en) *	2020-03-13	2021-09-16	Cadila Healthcare Limited	Novel salts of quinolone compounds
KR20230159487A (ko) *	2021-03-19	2023-11-21	자이두스 라이프사이언시즈 리미티드	고체 형태의 퀴놀론 화합물 및 이의 제조 방법

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3175944A (en) *	1956-06-18	1965-03-30	Upjohn Co	Dihydronovobiocin and derivatives thereof
IL63968A (en)	1980-10-01	1985-10-31	Glaxo Group Ltd	Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
GB8320521D0 (en) *	1983-07-29	1983-09-01	Glaxo Group Ltd	Chemical process
JPS61171460A (ja) *	1985-01-23	1986-08-02	Dainippon Pharmaceut Co Ltd	塩酸メクロフエノキサ−ト１型結晶の製造法
JP2569746B2 (ja) *	1987-08-20	1997-01-08	日産化学工業株式会社	キノリン系メバロノラクトン類
JP2877366B2 (ja)	1988-08-25	1999-03-31	協和醗酵工業株式会社	結晶状ｌ−アスコルビン酸−２−リン酸ナトリウム塩の製造法
JP3528186B2 (ja) *	1991-06-24	2004-05-17	日産化学工業株式会社	光学活性キノリンメバロン酸のジアステレオマー塩
JPH0613526A (ja)	1992-06-25	1994-01-21	Seiko Epson Corp	半導体装置用リードフレーム及びその製造方法
JP2575590B2 (ja) *	1992-07-31	1997-01-29	塩野義製薬株式会社	トリアゾリルチオメチルチオセファロスポリン塩酸塩およびその水和物結晶ならびにそれらの製法
FR2694558B1 (fr)	1992-08-05	1994-10-28	Sanofi Elf	Monohydrate du sel disodique de l'acide 4-chlorophénylthiométhylène bisphosphonique, sa préparation, les compositions pharmaceutiques en contenant.
DE4235133A1 (de)	1992-10-19	1994-04-21	Bayer Ag	Kristallines (R)-(-)-2-Cycloheptyl-N-methylsulfonyl-[4-(2-chinolinyl-methoxy)-phenyl]-acetamid
JP3623531B2 (ja)	1993-06-07	2005-02-23	ビーエーエスエフアクチェンゲゼルシャフト	結晶質ｌ−アスコルビン酸−２−燐酸エステルマグネシウム塩の製造法
JP3558684B2 (ja) *	1994-06-28	2004-08-25	塩野義製薬株式会社	ピロリジルチオカルバペネム誘導体の乾燥方法
CZ20012357A3 (cs) *	1999-01-14	2001-09-12	Nissan Chemical Industries, Ltd.	Způsob přípravy chinolinkarbaldehydu
CA2450820C (en) *	2001-08-16	2011-03-15	Teva Pharmaceutical Industries Ltd.	Processes for preparing calcium salt forms of statins
US6835838B2 (en)	2002-01-28	2004-12-28	Novartis Ag	Process for the manufacture of organic compounds
CN1305853C (zh) *	2002-01-31	2007-03-21	诺瓦提斯公司	Hmg辅酶a还原酶抑制剂的制备方法
US6869970B2 (en) *	2002-02-04	2005-03-22	Novartis Ag	Crystalline salt forms of valsartan
CA2482937A1 (en) *	2002-04-17	2003-10-23	Yamanouchi Pharmaceutical Co., Ltd.	A novel crystal of anhydride of a quinoxalinedione derivative
CA2513837A1 (en) *	2003-02-12	2004-08-26	Paul Adriaan Van Der Schaaf	Crystalline forms of pitavastatin calcium
TWI328006B (en) *	2003-12-26	2010-08-01	Nissan Chemical Ind Ltd	Crystal form of quinoline compound and process for its production

2004
- 2004-11-29 TW TW093136780A patent/TWI328006B/zh not_active IP Right Cessation
- 2004-12-17 KR KR1020067011877A patent/KR20070001910A/ko not_active Ceased
- 2004-12-17 KR KR1020207003201A patent/KR20200015826A/ko not_active Withdrawn
- 2004-12-17 ZA ZA200605658A patent/ZA200605658B/en unknown
- 2004-12-17 KR KR1020137001739A patent/KR20130014643A/ko not_active Withdrawn
- 2004-12-17 RU RU2006127044/04A patent/RU2370489C2/ru not_active Application Discontinuation
- 2004-12-17 ES ES04807807T patent/ES2367172T3/es not_active Expired - Lifetime
- 2004-12-17 DK DK04807807.5T patent/DK1697326T3/da active
- 2004-12-17 KR KR1020177001565A patent/KR20170010111A/ko not_active Withdrawn
- 2004-12-17 PT PT04807807T patent/PT1697326E/pt unknown
- 2004-12-17 KR KR1020187035028A patent/KR20180132973A/ko not_active Withdrawn
- 2004-12-17 AT AT04807807T patent/ATE518835T1/de active
- 2004-12-17 KR KR1020197019411A patent/KR20190083674A/ko not_active Withdrawn
- 2004-12-17 KR KR1020187010082A patent/KR20180040732A/ko not_active Withdrawn
- 2004-12-17 KR KR1020207032499A patent/KR20200130510A/ko not_active Ceased
- 2004-12-17 KR KR1020167016139A patent/KR20160075844A/ko not_active Withdrawn
- 2004-12-17 SI SI200431760T patent/SI1697326T1/sl unknown
- 2004-12-17 US US10/584,208 patent/US20070112024A1/en not_active Abandoned
- 2004-12-17 PL PL04807807T patent/PL1697326T3/pl unknown
- 2004-12-17 WO PCT/JP2004/019451 patent/WO2005063711A1/en not_active Ceased
- 2004-12-17 NZ NZ548041A patent/NZ548041A/en not_active IP Right Cessation
- 2004-12-17 KR KR1020117002847A patent/KR20110017936A/ko not_active Ceased
- 2004-12-17 MX MX2011007418A patent/MX338019B/es unknown
- 2004-12-17 EP EP04807807A patent/EP1697326B1/en not_active Expired - Lifetime
- 2004-12-17 CN CN201110198613.7A patent/CN102321019B/zh not_active Expired - Lifetime
- 2004-12-17 JP JP2006520594A patent/JP5186108B2/ja not_active Expired - Lifetime
- 2004-12-17 CA CA2551050A patent/CA2551050C/en not_active Expired - Lifetime
- 2004-12-17 AU AU2004309241A patent/AU2004309241A1/en not_active Abandoned
- 2004-12-17 CN CNA2004800389550A patent/CN1898211A/zh active Pending
- 2004-12-17 KR KR1020177023135A patent/KR20170098976A/ko not_active Withdrawn
2006
- 2006-06-21 IL IL176470A patent/IL176470A/en active IP Right Grant
2009
- 2009-03-11 US US12/401,945 patent/US20090176987A1/en not_active Abandoned
2010
- 2010-12-13 US US12/966,102 patent/US20110082298A1/en not_active Abandoned
2011
- 2011-08-18 AU AU2011213742A patent/AU2011213742C1/en not_active Expired
- 2011-09-07 US US13/227,003 patent/US20110319624A1/en not_active Abandoned
- 2011-10-20 CY CY20111100995T patent/CY1112464T1/el unknown
- 2011-11-29 JP JP2011260984A patent/JP5267643B2/ja not_active Expired - Lifetime
2012
- 2012-06-04 US US13/487,289 patent/US20120245200A1/en not_active Abandoned
2013
- 2013-03-15 US US13/832,285 patent/US20130204000A1/en not_active Abandoned
- 2013-04-05 JP JP2013079889A patent/JP2013136640A/ja not_active Withdrawn
- 2013-10-30 US US14/066,762 patent/US20140058109A1/en not_active Abandoned
2014
- 2014-03-21 US US14/221,372 patent/US20140206719A1/en not_active Abandoned
- 2014-08-01 JP JP2014157888A patent/JP2014205719A/ja not_active Withdrawn
2015
- 2015-02-18 US US14/625,046 patent/US20150158816A1/en not_active Abandoned
- 2015-11-16 JP JP2015224264A patent/JP2016029102A/ja not_active Withdrawn
2016
- 2016-09-15 US US15/266,095 patent/US20170226061A1/en not_active Abandoned
- 2016-11-22 JP JP2016227123A patent/JP2017061536A/ja not_active Withdrawn
2017
- 2017-11-15 US US15/813,422 patent/US20180072676A1/en not_active Abandoned
2018
- 2018-01-10 JP JP2018002103A patent/JP2018052988A/ja not_active Withdrawn
- 2018-06-19 US US16/011,870 patent/US20180297956A1/en not_active Abandoned
2019
- 2019-01-24 US US16/256,070 patent/US20190152916A1/en not_active Abandoned
- 2019-08-19 US US16/543,653 patent/US20190367458A1/en not_active Abandoned
2020
- 2020-03-16 US US16/819,317 patent/US20200216395A1/en not_active Abandoned
- 2020-11-05 US US17/090,353 patent/US20210053923A1/en not_active Abandoned
2022
- 2022-02-28 US US17/682,065 patent/US20220177433A1/en not_active Abandoned
2023
- 2023-06-14 US US18/334,683 patent/US20230322679A1/en not_active Abandoned
2024
- 2024-04-17 US US18/637,529 patent/US20240294476A1/en not_active Abandoned

Also Published As

Publication number	Publication date
RU2006127044A (ru)	2008-02-10
AU2011213742A1 (en)	2011-09-08
US20150158816A1 (en)	2015-06-11
KR20160075844A (ko)	2016-06-29
US20230322679A1 (en)	2023-10-12
US20170226061A1 (en)	2017-08-10
US20110082298A1 (en)	2011-04-07
KR20170010111A (ko)	2017-01-25
US20190152916A1 (en)	2019-05-23
ATE518835T1 (de)	2011-08-15
CN102321019A (zh)	2012-01-18
CA2551050C (en)	2020-06-02
SI1697326T1 (sl)	2011-11-30
JP2018052988A (ja)	2018-04-05
JP2007516952A (ja)	2007-06-28
KR20200015826A (ko)	2020-02-12
EP1697326A1 (en)	2006-09-06
AU2004309241A1 (en)	2005-07-14
JP2016029102A (ja)	2016-03-03
US20090176987A1 (en)	2009-07-09
MX338019B (es)	2016-03-29
CA2551050A1 (en)	2005-07-14
JP2013136640A (ja)	2013-07-11
US20140206719A1 (en)	2014-07-24
HK1095328A1 (en)	2007-05-04
US20140058109A1 (en)	2014-02-27
US20110319624A1 (en)	2011-12-29
KR20110017936A (ko)	2011-02-22
AU2011213742C1 (en)	2017-04-06
US20130204000A1 (en)	2013-08-08
CN102321019B (zh)	2016-06-08
KR20190083674A (ko)	2019-07-12
US20240294476A1 (en)	2024-09-05
KR20130014643A (ko)	2013-02-07
JP2012072175A (ja)	2012-04-12
IL176470A0 (en)	2006-10-05
ES2367172T3 (es)	2011-10-31
AU2011213742B2 (en)	2014-05-15
WO2005063711A1 (en)	2005-07-14
DK1697326T3 (da)	2011-09-19
US20180297956A1 (en)	2018-10-18
KR20170098976A (ko)	2017-08-30
US20120245200A1 (en)	2012-09-27
KR20200130510A (ko)	2020-11-18
IL176470A (en)	2011-10-31
JP2017061536A (ja)	2017-03-30
JP5267643B2 (ja)	2013-08-21
US20200216395A1 (en)	2020-07-09
US20220177433A1 (en)	2022-06-09
JP2014205719A (ja)	2014-10-30
KR20070001910A (ko)	2007-01-04
US20180072676A1 (en)	2018-03-15
TW200530186A (en)	2005-09-16
RU2370489C2 (ru)	2009-10-20
TWI328006B (en)	2010-08-01
US20190367458A1 (en)	2019-12-05
CN1898211A (zh)	2007-01-17
KR20180132973A (ko)	2018-12-12
ZA200605658B (en)	2007-11-28
NZ548041A (en)	2010-04-30
KR20180040732A (ko)	2018-04-20
EP1697326B1 (en)	2011-08-03
US20070112024A1 (en)	2007-05-17
CY1112464T1 (el)	2015-12-09
PT1697326E (pt)	2011-09-12
JP5186108B2 (ja)	2013-04-17
US20210053923A1 (en)	2021-02-25

Publication	Publication Date	Title
TWI328006B (en)	2010-08-01	Crystal form of quinoline compound and process for its production
BG105547A (en)	2001-12-31	Ethanolate of azithromycin, process for manufacture, and pharmaceutical compositions thereof
MY148096A (en)	2013-02-28	4,5-diphenyl-pyrimidinyl-amino substituted carboxylic acids, method for the production and use thereof as medicaments
MY142799A (en)	2010-12-31	Fluoro substituted omega-carboxyaryl diphenyl urea for the treatment and prevention of diseases and conditions
EA200900817A1 (ru)	2009-12-30	Способ получения фторметилзамещённых гетероциклических соединений
MX2007006311A (es)	2007-07-11	Acidos hidroxibifenilcarboxilicos y derivados, metodo para producirlos y su uso.
BG106389A (en)	2002-09-30	Crystals of the sodium salt of pravastatin
YU94103A (sh)	2006-03-03	Novi derivati sulfonske kiseline
UA72895C2 (uk)	2005-05-16	Нова кристалічна модифікація n торасеміду
SI1751093T1 (sl)	2011-01-31	Substituirani derivati cikloheksilocetne kisline
PL1745010T3 (pl)	2010-01-29	Podstawione pochodne cykloheksylo-1,4-diaminy
TW200612959A (en)	2006-05-01	Method for preparing hydroxamic acids
DE60335865D1 (de)	2011-03-10	Verfahren zur herstellung von cilostazol
EP1694645A4 (en)	2009-03-04	AMLODIPINE GENTISATE AND METHOD OF MANUFACTURE
WO2006066044A3 (en)	2007-05-10	Processes for producing 4-aminoquinazolines
GB0417063D0 (en)	2004-09-01	Process for the preparation of optically-active compounds
ATE270296T1 (de)	2004-07-15	Verfahren zur herstellung von hochkristallinem natrium cefoperazon
MXPA05008331A (es)	2005-09-30	Derivados de 3-(benzoilureido)-tiofeno sustituido, metodo para su produccion y uso de los mismos.
NZ589496A (en)	2013-02-22	Processes and compounds for the preparation of normorphinans
AP2002002587A0 (en)	2002-09-30	Calcium dicarboxylate ethers, methods of making same, and treatment of vascular disease and diabetes therewith.
ATE533758T1 (de)	2011-12-15	Verfahren zur herstellung von enantiomerenreinem esomeprazol
DE602005013007D1 (de)	2009-04-09	Verfahren zur herstellung von lactonen
TW200637856A (en)	2006-11-01	Process for producing thiazolidinedion compound and intermediate thereof
DE60314904D1 (de)	2007-08-23	Verfahren zur herstellung von chinoloncarboxylat-derivaten
MX2022006569A (es)	2022-07-01	Proceso para la sintesis de una 2-tioalquilpirimidina.